- Home
- XPOF vs ZNTL Comparison
XPOF vs ZNTL Comparison
Compare XPOF & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- ZNTL
- Stock Information
- Founded
- XPOF 2017
- ZNTL 2014
- Country
- XPOF United States
- ZNTL United States
- Employees
- XPOF N/A
- ZNTL N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- ZNTL Health Care
- Exchange
- XPOF Nasdaq
- ZNTL Nasdaq
- Market Cap
- XPOF 295.1M
- ZNTL 105.8M
- IPO Year
- XPOF 2021
- ZNTL 2020
- Fundamental
- Price
- XPOF $10.04
- ZNTL $1.33
- Analyst Decision
- XPOF Buy
- ZNTL Buy
- Analyst Count
- XPOF 9
- ZNTL 7
- Target Price
- XPOF $13.94
- ZNTL $8.60
- AVG Volume (30 Days)
- XPOF 788.3K
- ZNTL 1.4M
- Earning Date
- XPOF 07-31-2025
- ZNTL 08-08-2025
- Dividend Yield
- XPOF N/A
- ZNTL N/A
- EPS Growth
- XPOF N/A
- ZNTL N/A
- EPS
- XPOF N/A
- ZNTL N/A
- Revenue
- XPOF $317,536,000.00
- ZNTL $26,865,000.00
- Revenue This Year
- XPOF $1.62
- ZNTL N/A
- Revenue Next Year
- XPOF $6.11
- ZNTL N/A
- P/E Ratio
- XPOF N/A
- ZNTL N/A
- Revenue Growth
- XPOF N/A
- ZNTL N/A
- 52 Week Low
- XPOF $6.64
- ZNTL $1.01
- 52 Week High
- XPOF $18.95
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- XPOF 63.94
- ZNTL 50.91
- Support Level
- XPOF $8.86
- ZNTL $1.15
- Resistance Level
- XPOF $10.14
- ZNTL $1.38
- Average True Range (ATR)
- XPOF 0.53
- ZNTL 0.10
- MACD
- XPOF 0.28
- ZNTL 0.01
- Stochastic Oscillator
- XPOF 93.97
- ZNTL 75.00
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.